id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0134-0186,FDA,FDA-2013-N-0134,MQSA Ref 34 Eastern Research Group Inc. - Baseline Quality Measures,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2022-07-19T15:48:51Z,,0,0,0900006484be9251
FDA-2013-N-0134-0166,FDA,FDA-2013-N-0134,MQSA Ref 17 - Kolb 2002 Radiol,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:48:40Z,,0,0,0900006484be8c3d
FDA-2013-N-0134-0180,FDA,FDA-2013-N-0134,MQSA Ref 27 - Ho 2014 AJR,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:04:44Z,,0,0,0900006484be8c4e
FDA-2013-N-0134-0184,FDA,FDA-2013-N-0134,MQSA Ref 31 - ACR BI-RADS pp 7-8,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:10:00Z,,0,0,0900006484be8c51
FDA-2013-N-0134-0158,FDA,FDA-2013-N-0134,MQSA Ref 9 - ACR breast density brochure,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:37:40Z,,0,0,0900006484be8c14
FDA-2013-N-0134-0161,FDA,FDA-2013-N-0134,MQSA Ref 12 - Boyd 2007 NEJM,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:43:15Z,,0,0,0900006484be8c17
FDA-2013-N-0134-0150,FDA,FDA-2013-N-0134,MQSA Ref 1 - CDC - Breast Cancer Statistics,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:25:39Z,,0,0,0900006484be869b
FDA-2013-N-0134-0165,FDA,FDA-2013-N-0134,MQSA Ref 16 - CDC - What Are the Risk Factors for Breast Cancer_,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:46:57Z,,0,0,0900006484be8c3c
FDA-2013-N-0134-0170,FDA,FDA-2013-N-0134,MQSA Ref 21 - Dense Breast Info website,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:54:41Z,,0,0,0900006484be8c41
FDA-2013-N-0134-0160,FDA,FDA-2013-N-0134,MQSA Ref 11 - McCormack 2006 CEBP,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:42:17Z,,0,0,0900006484be8c16
FDA-2013-N-0134-0155,FDA,FDA-2013-N-0134,MQSA Ref 6 - GAO report 2006,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:32:55Z,,0,0,0900006484be8c11
FDA-2013-N-0134-0152,FDA,FDA-2013-N-0134,MQSA Ref 3 - CDC - Cancer Statistics - Cancer Among Women,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:28:03Z,,0,0,0900006484be869d
FDA-2013-N-0134-0175,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 29 2006 - 2nd part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:59:33Z,,0,0,0900006484be8c49
FDA-2013-N-0134-0168,FDA,FDA-2013-N-0134,MQSA Ref 19 - Berg 2008 JAMA,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:53:17Z,,0,0,0900006484be8c3f
FDA-2013-N-0134-0172,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 28 2006 - 2nd part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:57:15Z,,0,0,0900006484be8c43
FDA-2013-N-0134-0176,FDA,FDA-2013-N-0134,MQSA Ref 23 - MQSA Alternative Standard 11_ Modifica,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:00:12Z,,0,0,0900006484be8c4a
FDA-2013-N-0134-0169,FDA,FDA-2013-N-0134,MQSA Ref 20 - NMQAAC summary 2011,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:53:56Z,,0,0,0900006484be8c40
FDA-2013-N-0134-0173,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 28 2006 - 3rd part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:57:58Z,,0,0,0900006484be8c44
FDA-2013-N-0134-0156,FDA,FDA-2013-N-0134,MQSA Ref 7 complete - US Senate Hearing 02-13-1991,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:35:04Z,,0,0,0900006484be8c12
FDA-2013-N-0134-0157,FDA,FDA-2013-N-0134,MQSA Ref 8 - US House Subcommittee Hearing 10-24-1991,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:36:29Z,,0,0,0900006484be8c13
FDA-2013-N-0134-0185,FDA,FDA-2013-N-0134,MQSA Ref 33 - FDA MQSA National Statistics 2018,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:10:48Z,,0,0,0900006484be9250
FDA-2013-N-0134-0177,FDA,FDA-2013-N-0134,MQSA Ref 24 - MQSA Alternative Standard 12_ Assessme,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:00:51Z,,0,0,0900006484be8c4b
FDA-2013-N-0134-0178,FDA,FDA-2013-N-0134,MQSA Ref 25 - Sickels ACR BI-RADS pp 123-126,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:02:56Z,,0,0,0900006484be8c4c
FDA-2013-N-0134-0154,FDA,FDA-2013-N-0134,MQSA Ref 5 - Americal Cancer Society - Breast Cancer Early Detection Recommendations,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:30:55Z,,0,0,0900006484be8c10
FDA-2013-N-0134-0159,FDA,FDA-2013-N-0134,MQSA Ref 10 - American College of Radiology-Society of Breast Imaging,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:38:37Z,,0,0,0900006484be8c15
FDA-2013-N-0134-0163,FDA,FDA-2013-N-0134,MQSA Ref 14- Gastounioti Beyond Breast Density 2016,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:45:12Z,,0,0,0900006484be8c19
FDA-2013-N-0134-0167,FDA,FDA-2013-N-0134,MQSA Ref 18 - Leconte 2003 AJR,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:49:30Z,,0,0,0900006484be8c3e
FDA-2013-N-0134-0171,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 28 2006 - 1st part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:56:26Z,,0,0,0900006484be8c42
FDA-2013-N-0134-0179,FDA,FDA-2013-N-0134,MQSA Ref 26 - Am Cancer Soc breast density brochure,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:03:54Z,,0,0,0900006484be8c4d
FDA-2013-N-0134-0183,FDA,FDA-2013-N-0134,MQSA Ref 32 - Mammography_PRIA.FDA-2013-N-0134,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:09:04Z,,0,0,0900006484be8c50
FDA-2013-N-0134-0181,FDA,FDA-2013-N-0134,MQSA Ref 30 - ACR BI-RADS Outcomes Monitoring,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:05:55Z,,0,0,0900006484be924f
FDA-2013-N-0134-0182,FDA,FDA-2013-N-0134,MQSA Ref 28  - Melnikow 2016 Ann Int Med,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:07:13Z,,0,0,0900006484be8c4f
FDA-2013-N-0134-0164,FDA,FDA-2013-N-0134,MQSA Ref 15 - Guterbock 2017,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:45:58Z,,0,0,0900006484be8c3b
FDA-2013-N-0134-0174,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 29 2006 - 1st part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:58:41Z,,0,0,0900006484be8c48
FDA-2013-N-0134-0151,FDA,FDA-2013-N-0134,MQSA Ref 2 - Female Breast Cancer - Cancer Stat Facts,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:27:05Z,,0,0,0900006484be869c
FDA-2013-N-0134-0153,FDA,FDA-2013-N-0134,MQSA Ref 4 - Michaelson 2002 Cancer,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:29:28Z,,0,0,0900006484be869e
FDA-2013-N-0134-0162,FDA,FDA-2013-N-0134,MQSA Ref 13 - Vachon 2007 Br Cancer Res,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:44:07Z,,0,0,0900006484be8c18